Next |
home / stock / ardx / ardx message board
Subject | By | Source | When |
---|---|---|---|
$ARDX Are we heading down to the daily | TripTrap | investorshub | 04/28/2023 2:08:33 PM |
1 year chart. You don't even need | Cosa | investorshub | 04/27/2023 9:07:48 PM |
Benny $ARDX is a BP buyout candidate like | Whalatane | investorshub | 04/22/2023 10:16:59 PM |
Agree. It looks fabulous! Would | Cosa | investorshub | 04/19/2023 8:28:20 PM |
If an offering occurs after approval and is, | Benny450 | investorshub | 04/19/2023 4:55:57 PM |
Mid November at the latest depending on review | Cosa | investorshub | 04/18/2023 7:56:52 PM |
Ardelyx announces the resubmission of a New Drug | Cosa | investorshub | 04/18/2023 6:48:44 PM |
Great News | Outcast27 | investorshub | 04/17/2023 4:46:03 PM |
$ARDX - 04/17/23 08:34.57 - Wedbush Maintains | TripTrap | investorshub | 04/17/2023 1:13:26 PM |
$ARDX Weekly. The continued long slow upward grind | TripTrap | investorshub | 04/16/2023 7:41:09 PM |
Ardelyx Presents Positive Data Further Supporting Efficacy and | TripTrap | investorshub | 04/12/2023 11:15:28 PM |
Added on this dip. NDA submission coming soon. | Cosa | investorshub | 04/10/2023 8:01:03 PM |
Since you recently got excited about $ARDX a | Benny450 | investorshub | 04/10/2023 4:27:44 PM |
As you are the self proclaimed expert on | Benny450 | investorshub | 04/06/2023 4:28:21 PM |
Benny. Again with the personal attacks . | Whalatane | investorshub | 04/06/2023 4:18:38 PM |
Those of us here for many months or | Benny450 | investorshub | 04/06/2023 4:02:48 PM |
Ahh Benny ...so typical of your posts ...all | Whalatane | investorshub | 04/06/2023 3:17:30 PM |
Cosa, that's his MO. Latch | Benny450 | investorshub | 04/06/2023 1:24:39 PM |
There is no challenge, stop bringing this bs | Cosa | investorshub | 04/05/2023 7:01:47 PM |
Well they definitely want XPHOZAH approved in | Whalatane | investorshub | 04/05/2023 6:34:57 PM |
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, ...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...
WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, d...